輸入代號或公司名稱後按 Enter
4728

雙美

-3.00 (-0.76%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
392.0011成交張數26.51本益比15.04股價淨值比3.06%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入20252,026年增 +11.4%
毛利率202578.4%最新一期
營業利益率202549.3%最新一期
每股盈餘202513.33年增 +6.9%
會計項目走勢2016201720182019202020212022202320242025
銷貨收入101.1%100.2%100.0%100.0%100.0%100.0%100.0%100.7%100.5%100.7%
銷貨折讓0.0%0.2%0.5%0.7%
銷貨收入淨額100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
銷貨成本36.3%27.6%21.0%13.3%18.1%13.6%14.8%16.8%18.7%21.6%
營業成本合計36.3%27.6%21.0%13.3%18.1%13.6%14.8%16.8%18.7%21.6%
營業毛利(毛損)63.7%72.4%79.0%86.7%81.9%86.4%85.2%83.2%81.3%78.4%
營業毛利(毛損)淨額63.7%72.4%79.0%86.7%81.9%86.4%85.2%83.2%81.3%78.4%
推銷費用18.3%28.3%26.2%31.1%25.7%33.4%16.1%18.6%17.6%17.0%
管理費用30.9%30.9%25.4%15.1%15.7%15.1%12.9%9.9%10.6%10.1%
研究發展費用12.6%6.2%6.4%3.3%2.0%2.4%1.3%1.7%2.2%2.1%
營業費用合計61.8%65.4%58.4%49.9%43.1%50.9%30.3%30.2%30.3%29.1%
營業利益(損失)2.0%7.0%20.7%36.8%38.8%35.5%54.9%53.0%51.0%49.3%
利息收入0.4%0.8%0.6%0.6%
其他收入6.8%5.7%12.2%2.2%1.6%0.5%0.4%0.2%0.4%0.3%
其他利益及損失淨額-6.2%-1.5%-4.1%-4.8%-0.6%-1.1%-0.0%0.0%0.8%0.2%
財務成本淨額0.4%0.3%0.3%0.1%0.2%0.3%0.2%
營業外收入及支出合計0.7%4.2%8.1%-3.0%0.6%-1.0%0.7%0.9%1.4%0.8%
稅前淨利(淨損)2.7%11.2%28.7%33.7%39.5%34.5%55.5%53.8%52.4%50.1%
所得稅費用(利益)合計1.5%2.5%4.2%11.5%11.6%10.8%17.4%16.8%15.1%14.3%
繼續營業單位本期淨利(淨損)1.1%8.7%24.6%22.3%27.8%23.7%38.1%37.0%37.4%35.8%
本期淨利(淨損)1.1%8.7%24.6%22.3%27.8%23.7%38.1%37.0%37.4%35.8%
國外營運機構財務報表換算之兌換差額-3.5%0.3%-1.4%-1.2%0.6%-0.2%0.0%-0.6%0.4%0.7%
與可能重分類之項目相關之所得稅-0.6%0.0%-0.3%0.0%-0.1%-0.0%0.0%-0.1%0.1%0.1%
後續可能重分類至損益之項目:-1.2%0.8%-0.2%0.0%-0.5%0.4%0.5%
其他綜合損益(淨額)-3.0%0.5%-0.0%-0.9%0.6%-0.2%0.5%-0.4%0.4%0.5%
本期綜合損益總額-1.9%9.2%24.5%21.4%28.4%23.5%38.7%36.6%37.7%36.4%
母公司業主(淨利∕損)1.1%8.7%24.6%22.3%27.8%23.7%38.1%37.0%37.4%35.8%
母公司業主(綜合損益)-1.9%9.2%24.5%21.4%28.4%23.5%38.7%36.6%37.7%36.4%
基本每股盈餘0.0%0.2%0.5%0.4%0.5%0.4%0.7%0.7%0.7%0.7%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.4%0.5%0.4%0.7%0.7%0.7%0.7%
銷貨退回1.1%0.2%0.0%0.5%0.0%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益1.3%0.3%-0.2%0.0%0.5%0.1%0.0%
不重分類至損益之項目:0.3%-0.2%0.0%0.5%0.1%0.0%
預期信用減損損失(利益)0.4%0.4%-0.3%0.0%-0.0%0.0%
確定福利計畫之再衡量數-0.2%0.2%-0.2%0.0%0.0%0.0%0.0%
與不重分類之項目相關之所得稅-0.0%0.0%-0.0%0.0%0.0%0.0%0.0%
備供出售金融資產未實現評價損益0.1%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。